Assessment of retroperitoneal lymph node status in locally advanced cervical cancer
- PMID: 33933005
- PMCID: PMC8088051
- DOI: 10.1186/s12885-021-08208-6
Assessment of retroperitoneal lymph node status in locally advanced cervical cancer
Abstract
Background: The assessment of retroperitoneal lymph node status in patients with locally advanced cervical cancer is still a problem. This study aimed to explore the choice of these assessment methods.
Methods: Laparoscopic retroperitoneal lymphadenectomy was performed in 96 patients with advanced cervical cancer. The positive rates of lymph node metastasis were analyzed. The values of computed tomography lymph node minimum axial diameter (MAD) and squamous cell carcinoma antigen (SCC-Ag), and their combination in predicting retroperitoneal lymph node metastasis were compared. High-risk factors for common iliac lymph node (CILN) and/or para-aortic lymph node (PALN) metastasis were analyzed.
Results: The lymph node metastasis rate was 62.50% and the CILN and/or PALN metastasis rate was 31.25%. Overall, 96 patients had 172 visible lymph nodes. The positive rate of lymph node metastasis was significantly higher in the MAD ≥1.0 cm group (83.33%) than in the 0.5 cm ≤ MAD < 1.0 cm group (26.82%). The critical values of MAD and SCC-Ag in determining lymph node metastasis were 1.0 cm and 5.2 ng/mL, respectively. The accuracy, specificity, and Youden index of MAD ≥1.0 cm combined with SCC-Ag ≥ 5.2 ng/mL for evaluating lymph node metastasis were 75.71%, 100%, and 0.59, respectively, and were significantly different from the values for the MAD ≥1.0 cm (72.09%, 80.56%, and 0.47, respectively) and SCC-Ag ≥ 5.2 ng/mL (71.43%, 68.97%, and 0.42, respectively) groups. Correlation analysis showed that non-squamous cell carcinoma, pelvic lymph node (PLN) MAD ≥1.0 cm plus number ≥ 2, and 1 PLN MAD ≥1.0 cm with CILN and/or PALN MAD 0.5-1.0 cm were risk factors for CILN and/or PALN metastasis.
Conclusion: Patients with MAD ≥1.0 cm and SCC-Ag ≥ 5.2 ng/mL, as well as high risk factors for CILN and/or PALN metastasis, should undergo resection of enlarged lymph nodes below the common iliac gland and lymphadenectomy of CILN/PALN to reduce tumor burden and to clarify lymph node metastasis status for accurate guidance in follow-up treatment. Patients with MAD < 1.0 cm and SCC-Ag < 5.2 ng/mL may be treated with chemoradiotherapy directly based on imaging, given the low lymph node metastasis rate.
Keywords: Cervical neoplasm; Computed tomography (CT); Retroperitoneal lymph node; Squamous cell carcinoma antigen (SCC-Ag).
Conflict of interest statement
The authors declare that they had no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8088051/bin/12885_2021_8208_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8088051/bin/12885_2021_8208_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8088051/bin/12885_2021_8208_Fig3_HTML.gif)
Similar articles
-
[The indication and surgery scope for laparoscopic extraperitoneal lymphadenectomy in locally advanced cervical cancer].Zhonghua Zhong Liu Za Zhi. 2019 Apr 23;41(4):303-308. doi: 10.3760/cma.j.issn.0253-3766.2019.04.011. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31014057 Chinese.
-
Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.Int J Gynecol Cancer. 2017 Nov;27(9):1935-1942. doi: 10.1097/IGC.0000000000001112. Int J Gynecol Cancer. 2017. PMID: 28914639
-
[Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].Zhonghua Zhong Liu Za Zhi. 2019 May 23;41(5):357-362. doi: 10.3760/cma.j.issn.0253-3766.2019.05.007. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31137169 Chinese.
-
Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.Gynecol Oncol. 2022 Mar;164(3):667-674. doi: 10.1016/j.ygyno.2021.12.026. Epub 2021 Dec 27. Gynecol Oncol. 2022. PMID: 34969533 Review.
-
First birth after uterine transposition in low-volume lymph node metastasis of cervical cancer: A long journey for success.J Surg Oncol. 2024 Aug 13. doi: 10.1002/jso.27805. Online ahead of print. J Surg Oncol. 2024. PMID: 39138911 Review.
Cited by
-
Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?Radiat Oncol. 2022 Oct 20;17(1):167. doi: 10.1186/s13014-022-02132-0. Radiat Oncol. 2022. PMID: 36266716 Free PMC article.
References
-
- Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI, Hershman DL. Prognostic performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines. Obstet Gynecol. 2019;134(1):49–57. doi: 10.1097/AOG.0000000000003311. - DOI - PMC - PubMed
-
- Heller PB, Malfetano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis--a gynecologic oncology group study. Gynecol Oncol. 1990;38(3):425–430. doi: 10.1016/0090-8258(90)90085-Y. - DOI - PubMed
-
- Matsuo K, Shimada M, Saito T, Takehara K, Tokunaga H, Watanabe Y, Todo Y, Morishige KI, Mikami M, Sugiyama T. Risk stratification models for Para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer. J Gynecol Oncol. 2018;29(1):e11. doi: 10.3802/jgo.2018.29.e11. - DOI - PMC - PubMed
-
- Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, Fujimoto T, Oikawa M, Fujino T, Fujimoto S. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85(7):1547–1554. doi: 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2. - DOI - PubMed
-
- Huang L, Huang ZJ, Gao K. Advances in research on the treatment of cervical cancer with Para-aortic extension field radiotherapy. Chin J Obstet Gynecol. 2017;52(10):717–720.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials